Luis G. Ortega-Paz - Publications

Individual Participant Data Meta-Analysis (IPDMA) of long-term COVID-19 outcomes in a systematic review-informed, international, multidisciplinary database.

Journal: Health and social care delivery research

Published: August 28, 2026

De-escalation of antiplatelet therapy to evaluate platelet reactivity and clinical outcomes after coronary stenting in patients at high bleeding risk and recent acute coronary syndrome: Rationale and design of the DESC-HBR trial.

Journal: Cardiovascular revascularization medicine : including molecular interventions

Published: May 11, 2026

Slow flow and no reflow after percutaneous coronary intervention.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: May 04, 2026

Optimal timing of aspirin discontinuation after acute coronary syndrome treated with percutaneous coronary intervention: a systematic review and meta-analysis.

Journal: Heart (British Cardiac Society)

Published: April 16, 2026

Effect of Dapagliflozin on Myocardial Fibrosis After STEMI: A Double-Blind, Placebo-Controlled Randomized Trial.

Journal: Journal of clinical medicine

Published: April 15, 2026

In Hospital Assessment and Management of High Bleeding Risk in Patients with ST-Elevation Myocardial Infarction (STEMI).

Journal: Journal of cardiovascular development and disease

Published: January 31, 2026

Derivation and validation of a prediction model for long-term mortality in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the PREDICT-ST-Elevation Myocardial Infarction score.

Journal: Heart (British Cardiac Society)

Published: January 08, 2026

The pharmacology and clinical evidence for the use of dual versus single antiplatelet therapy.

Journal: Expert review of clinical pharmacology

Published: January 06, 2026

Trends in 90-Day Mortality, Recurrent Venous Thrombosis, and Bleeding in Patients With Pulmonary Embolism.

Journal: Journal of the American College of Cardiology

Published: December 10, 2025

Safety and optimal use of direct oral anticoagulant therapy.

Journal: Expert opinion on drug safety

Published: November 10, 2025

Long-term safety of oral antiplatelet strategies for patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Journal: Expert opinion on drug safety

Published: November 06, 2025

Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled Studies.

Journal: Thrombosis and haemostasis

Published: October 10, 2025